Dionaldo, Rose D.
HRN: 12-94-88 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/01/2022
CEFUROXIME 500MG (TAB)
10/01/2022
10/07/2022
PO
500 Mg
BID
S/p Pelvic Lap
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes